Gem Pharmaceuticals' Angel Round

Gem Pharmaceuticals raised a round of funding on March 19, 2014.

Gem Pharmaceuticals is a clinical-stage biopharmaceutical company developing anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class…

Articles about Gem Pharmaceuticals' Angel Round: